|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|
| Assets: | |||
| Current assets | |||
| Cash | |||
| Prepaid expenses | |||
| Short-term prepaid insurance | |||
| Total current assets | |||
| Long-term prepaid insurance | |||
| Deferred offering costs | |||
| Assets held in trust account | |||
| TOTAL ASSETS | |||
| Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit: | |||
| Liabilities: | |||
| Current liabilities | |||
| Accrued expenses | |||
| Accounts payable and accrued expenses | |||
| Accrued offering costs | |||
| Promissory note – related party | |||
| Total current liabilities | |||
| Deferred underwriting fee payable | |||
| Total Liabilities | |||
| Ordinary shares subject to possible redemption, $0.0001 par value; 13,000,000 and 0 shares at redemption value of $10.13 and $0 per share at June 30, 2026 and December 31, 2025, respectively | |||
| Shareholders’ Deficit: | |||
| Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 4,723,333 and 4,983,333 shares issued and outstanding (excluding 13,000,000 and 0 shares subject to possible redemption) at June 30, 2026 and December 31, 2025, respectively | |||
| Additional paid-in capital | |||
| Accumulated deficit | |||
| Total Shareholders’ Deficit | |||
| Total Liabilities, Ordinary Shares Subject to Possible Redemption and Shareholders’ Deficit |
Loading...
